サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566840

アメーバ細胞溶解液市場：タイプ別、用途別：世界の機会分析と産業予測、2024～2033年

Amebocyte Lysate Market By Type (Limulus Amebocyte Lysate, Tachypleus Amebocyte Lysate) , By Application (Drug Testing, Clinical Diagnosis, Other) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アメーバ細胞溶解液市場：タイプ別、用途別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アメーバ細胞溶解液市場

アメーバ細胞溶解液市場は、2023年に6億米ドルと評価され、2024～2033年にかけてCAGR 11.8%で成長し、2033年には19億米ドルに達すると予測されています。

アメーバ細胞溶解液は、カブトガニの血液細胞またはアメーバ細胞から得られるもので、細菌性内毒素の存在下で凝固するというユニークな特性でよく知られています。アメーバ溶解液は、バイオメディカル研究や医薬品のセグメントで重要な成分であり、特に細菌性エンドトキシンの検出に利用されています。アメーバ細胞溶解液は、その卓越した感度から、環境モニタリング、特に水やその他の環境サンプルの細菌汚染の品質評価に使用されています。

薬剤試験のセグメントは、アメーバ細胞溶解液市場の重要な促進要因です。原料試験、工程内試験、最終製品試験など、医薬品試験のいくつかの段階で、アメーバ細胞溶解液と辺縁系アメーバ細胞溶解液（LAL）試験が医薬品開発に利用されています。最近では、様々な用途でアメーバ細胞溶解液の特性を利用するために、組換えDNA技術が動向しています。この技術は、アメーバ細胞溶解液の遺伝子成分のコピーを開発するもので、スケーラビリティ、一貫性、カブトガニの個体群への依存度の低減といった利点を記載しています。

しかし、各国で制定されている薬局方規制を遵守することは、市場関係者にとって複雑で費用のかかる課題であり、市場の成長を妨げています。さらに、試験における動物の使用や、アメーバ細胞溶解液の生産に使用される天然資源の持続可能性に関する倫理的配慮が、市場開拓の妨げとなっています。こうした問題に対処するため、研究・発見機関であるAmeboGenesis（TM）は、サステイナブルアメーバ細胞生産方法を導入しました。これは、カブトガニの脚の筋肉を刈り取り、培養し、全能性幹細胞を用いてアメーバ細胞に分化させるというサステイナブルアプローチを利用した革新的な方法です。このプロセスにより、アメーバ細胞の生産が大幅にコントロールされ、安定したLAL濃度と生産が保証されます。このアプローチにより、年間約80万匹のカブトガニの捕獲と出血を防ぐことができ、捕獲後の生存率は著しく低いです。

セグメントのレビュー

アメーバ細胞溶解液市場は、タイプ、用途、地域に区分されます。タイプ別では、辺縁系アメーバ細胞溶解液と胸腺アメーバ細胞溶解液に二分されます。用途別では、薬剤試験、臨床診断、その他に分けられます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

タイプ別では、2023年には辺縁アメーバ細胞溶解液セグメントが主要株主でした。

用途別では、薬剤試験セグメントが2023年に主要シェアを獲得しました。

アメーバ細胞溶解液市場は、2033年にアジア太平洋で急成長が見込まれます。

本レポートのカスタマイズが可能です（別途費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 アメーバ細胞溶解液市場：タイプ別

  • 市場概要
  • 辺縁系アメーバ細胞溶解液
  • 胸腺アメーバ細胞溶解液

第5章 アメーバ細胞溶解液市場：用途別

  • 市場概要
  • 薬剤試験
  • 臨床診断
  • その他

第6章 アメーバ細胞溶解液市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国のアメーバ細胞溶解液市場
    • カナダのアメーバ細胞溶解液市場
    • メキシコのアメーバ細胞溶解液市場
  • 欧州
    • 主要市場動向と機会
    • ドイツのアメーバ細胞溶解液市場
    • フランスのアメーバ細胞溶解液市場
    • 英国のアメーバ細胞溶解液市場
    • イタリアのアメーバ細胞溶解液市場
    • スペインのアメーバ細胞溶解液市場
    • その他の欧州のアメーバ細胞溶解液の市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本のアメーバ細胞溶解液市場
    • 中国のアメーバ細胞溶解液市場
    • オーストラリアのアメーバ細胞溶解液市場
    • インドのアメーバ細胞溶解液市場
    • 韓国のアメーバ細胞溶解液市場
    • その他のアジア太平洋のアメーバ細胞溶解液市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのアメーバ細胞溶解液市場
    • サウジアラビアのアメーバ細胞溶解液市場
    • 南アフリカのアメーバ細胞溶解液市場
    • その他のラテンアメリカ・中東・アフリカのアメーバ細胞溶解液市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • Lonza Group AG
  • Charles River Laboratories
  • Associates of Cape Cod Inc
  • Xiamen Bioendo Technology
  • Zhanjiang A&C Biological
  • Genscript Technology Corporation
  • Nelson Laboratories, LLC
  • Thermo Fisher Scientific, Inc.
  • Merck And Co., Inc.
  • Microcoat Biotechnologie GmbH
目次
Product Code: A65445

Amebocyte Lysate Market

The amebocyte lysate market was valued at $0.6 billion in 2023 and is projected to reach $1.9 billion by 2033, growing at a CAGR of 11.8% from 2024 to 2033.

Amebocyte lysate, derived from the blood cells or amebocytes of horseshoe crabs, is well-known for its unique property of clotting in the presence of bacterial endotoxins. It is a crucial component in the field of biomedical research & pharmaceuticals and is particularly utilized for the detection of bacterial endotoxins. Due to its exceptional sensitivity, amebocyte lysate is used in environmental monitoring, particularly for the assessment of quality of water and other environmental samples for bacterial contamination.

The field of drug testing is a significant driver of the amebocyte lysate market. Several stages of drug testing such as raw material testing, in-process testing, and final product testing make use of amebocyte lysate and limulus amebocyte lysate (LAL) test for pharmaceutical development. In recent times, recombinant DNA technology is trending for the utilization of properties of amebocyte lysate in different applications. Ther technology develops copies of the genetic components of amebocyte lysate and offers benefits such as scalability, consistency, & reduced reliance on horseshoe crab populations.

However, compliance with the pharmacopeial regulations established in different countries is a complex and expensive challenge for the market players which prevents the growth of the market. In addition, the ethical considerations regarding the usage of animals in testing and the sustainability of natural resources used in amebocyte lysate production hinder market development. To combat such issues, AmeboGenesis(TM), a research and discovery organization, introduced a sustainable way of production of amebocytes. This is an innovative method which utilizes a sustainable approach involving the reaping of leg muscles of a horseshoe crab, culturing, and differentiating them into amebocytes by the use of totipotent stem cells. This process ensures a significant control over amebocyte production, along with consistent LAL concentration & production. This approach prevents the annual harvest and bleeding of approximately 800,000 horseshoe crabs, with a notably low survival rate post-harvesting.

Segment Review

The amebocyte lysate market is segmented into type, application, and region. By type, the market is bifurcated into limulus amebocyte lysate and tachypleus amebocyte lysate. On the basis of application, it is divided into drug testing, clinical diagnosis, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the limulus amebocyte lysate segment was the major shareholder in 2023.

Depending on application, the drug testing segment garnered a major share in 2023.

The amebocyte lysate market is expected to experience rapid growth In Asia Pacific by 2033.

Competition Analysis

The major players operating in the global amebocyte lysate market include Lonza Group AG, Charles River Laboratories, Associates Of Cape Cod, Xiamen Bioendo Technology, Zhanjiang A&c Biological, GenScript, Nelson Laboratories, LLC, Thermo Fisher Scientific, Inc., Merck & Co, and Microcoat Biotechnologie GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Limulus Amebocyte Lysate
  • Tachypleus Amebocyte Lysate

By Application

  • Drug Testing
  • Clinical Diagnosis
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Lonza Group AG
    • Charles River Laboratories
    • Associates of Cape Cod Inc
    • Xiamen Bioendo Technology
    • Zhanjiang A&C Biological
    • Genscript Technology Corporation
    • Nelson Laboratories, LLC
    • Thermo Fisher Scientific, Inc.
    • Merck & Co., Inc.
    • Microcoat Biotechnologie GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: AMEBOCYTE LYSATE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Limulus Amebocyte Lysate
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Tachypleus Amebocyte Lysate
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: AMEBOCYTE LYSATE MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Drug Testing
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinical Diagnosis
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Other
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: AMEBOCYTE LYSATE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By Application
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Amebocyte Lysate Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By Application
    • 6.2.6. Canada Amebocyte Lysate Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By Application
    • 6.2.7. Mexico Amebocyte Lysate Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By Application
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By Application
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Amebocyte Lysate Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By Application
    • 6.3.6. France Amebocyte Lysate Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By Application
    • 6.3.7. UK Amebocyte Lysate Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By Application
    • 6.3.8. Italy Amebocyte Lysate Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By Application
    • 6.3.9. Spain Amebocyte Lysate Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By Application
    • 6.3.10. Rest of Europe Amebocyte Lysate Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By Application
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Amebocyte Lysate Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By Application
    • 6.4.6. China Amebocyte Lysate Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By Application
    • 6.4.7. Australia Amebocyte Lysate Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By Application
    • 6.4.8. India Amebocyte Lysate Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By Application
    • 6.4.9. South Korea Amebocyte Lysate Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By Application
    • 6.4.10. Rest of Asia-Pacific Amebocyte Lysate Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By Application
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By Application
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Amebocyte Lysate Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By Application
    • 6.5.6. Saudi Arabia Amebocyte Lysate Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By Application
    • 6.5.7. South Africa Amebocyte Lysate Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By Application
    • 6.5.8. Rest of LAMEA Amebocyte Lysate Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Lonza Group AG
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Charles River Laboratories
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Associates of Cape Cod Inc
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Xiamen Bioendo Technology
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Zhanjiang A&C Biological
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Genscript Technology Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Nelson Laboratories, LLC
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Thermo Fisher Scientific, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Merck And Co., Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Microcoat Biotechnologie GmbH
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments